Dr. Huang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6363 France Ave S
Ste 610
Edina, MN 55435Phone+1 952-836-3645Fax+1 952-836-3646
Summary
- Dr. Jocelin Huang is an oncologist in Edina, MN, currently practicing at M Health Cancer Care. She received her medical degree from University of Chicago Pritzker School of Medicine and has been in practice 11 years. She specializes in breast cancer, high risk breast cancer prevention, CLL, lymphoma, multiple myeloma, gastrointestinal cancer, and is experienced in hematologic oncology, breast cancer, myelodysplasia, and myelofibrosis.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 2009 - 2013- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 2006 - 2009
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2006
Certifications & Licensure
MN State Medical License 2007 - 2025- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 194 citationsLow JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-f...A Tefferi, Terra L. Lasho, Jocelin Huang, Christy Finke, Ruben A. Mesa
Leukemia. 2008-01-24 - 34 citationsKaryotype complements the International Prognostic Scoring System for primary myelofibrosisKebede Hussein, Jocelin Huang, Terra L. Lasho, Animesh Pardanani, Ruben A. Mesa
European Journal of Haematology. 2009-04-01 - 61 citationsErythropoiesis stimulating agents have limited therapeutic activity in transfusion-dependent patients with primary myelofibrosis regardless of serum erythropoietin level.Jocelin Huang, Ayalew Tefferi
European Journal of Haematology. 2009-08-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
